noom med tirzepatide expands its GLP-1 range with 'microdose' package What Is Zepbound? Exploring Weight

doi: 10.1038/s41591-025-04106-7

Contents show The Triple-G Breakthrough: How Retatrutide Targets Three Metabolic Pathways The weight-loss landscape has evolved rapidly from single-hormone injections to the triple-action power of Retatrutide

Even at low doses (0.5mg weekly), semaglutide produces meaningful results with minimal side effects

Summary: No GLP-1 transdermal patches are currently licensed for use in the UK

This dual mechanism can help accelerate weight loss for some individuals compared to semaglutide alone

(2021) 12.6201 doi: 10.1038/s41467-021-26431-4 17 Bustamante-MarinXDevlinKLMcdonellSBDaveOMerlinoJLGrindstaffEJet al